```html

Keratitis Sicca (Dry Eye) – A Complete Guide

What is Keratitis Sicca (Dry Eye)?

Keratitis sicca, more commonly known as dry eye syndrome, is a multifactorial disease of the ocular surface characterized by insufficient quantity or quality of tears to maintain a healthy, lubricated cornea and conjunctiva. The condition can lead to inflammation, damage to the corneal epithelium, and visual disturbance if left untreated.

The tear film has three layers—oil (lipid), aqueous (water), and mucus—that work together to keep the eye moist, protect against infection, and provide a smooth optical surface. When any layer is deficient or abnormal, the eye becomes “dry,” resulting in the symptoms and signs described below.

According to the Mayo Clinic, dry eye affects up to 30 % of adults over 50 and is more common in women.

Common Causes

Dry eye is usually the result of an underlying condition rather than a single isolated factor. The most frequent contributors include:

• Age‑related tear production decline – lacrimal gland output naturally drops after age 40.
• Hormonal changes – especially reduced estrogen during menopause.
• Meibomian gland dysfunction (MGD) – blockage of oil‑secreting glands leads to rapid tear evaporation.
• Autoimmune diseases – Sjögren’s syndrome, rheumatoid arthritis, and lupus can damage tear‑producing glands.
• Environmental factors – wind, low humidity, air‑conditioning, or smoke accelerate tear evaporation.
• Medications – antihistamines, decongestants, antidepressants, beta‑blockers, and isotretinoin reduce tear production.
• Contact lens wear – lenses can disrupt the tear film and increase friction.
• Refractive surgery – LASIK or PRK may temporarily impair corneal nerves that stimulate tearing.
• Blepharitis – inflammation of the eyelid margins interferes with the lipid layer.
• Systemic conditions – diabetes, thyroid disorders, and vitamin A deficiency can affect ocular surface health.

Associated Symptoms

Patients with keratitis sicca often describe a constellation of uncomfortable sensations and visual changes. Commonly reported symptoms include:

• Burning, stinging, or gritty feeling (“like sand in the eye”)
• Blurred vision that improves with blinking
• Excessive tearing (reflex tearing) as the eye attempts to compensate
• Redness of the conjunctiva (pink eye)
• Photophobia – increased sensitivity to light
• Eye fatigue, especially after reading or screen use
• Difficulty wearing contact lenses
• Stringy mucus or crusting on the eyelashes upon waking

When to See a Doctor

Dry eye is often manageable with lifestyle changes, but certain signs warrant prompt evaluation by an eye‑care professional:

• Symptoms persisting longer than a few weeks despite over‑the‑counter lubricants.
• Sudden worsening of vision or persistent blurring that does not clear with blinking.
• Frequent eye infections or a feeling that the eye is “stuck open” (lagophthalmos).
• Severe redness, swelling, or pain that interferes with daily activities.
• History of autoimmune disease, recent eye surgery, or use of medications known to reduce tears.

Early professional assessment can prevent corneal damage and preserve visual function.

Diagnosis

Ophthalmologists and optometrists use a combination of patient history, visual‑acuity testing, and specific ocular surface examinations to confirm dry eye and determine its type (aqueous‑deficient vs. evaporative).

Standard Evaluation Tools

• Schirmer I Test – strips of filter paper placed under the lower eyelid for 5 minutes measure tear volume.
• Tear Break‑Up Time (TBUT) – fluorescein dye highlights the tear film; time until the first dry spot appears is recorded.
• Ocular Surface Staining – fluorescein, rose bengal, or lissamine green reveal epithelial damage.
• Meibomian Gland Assessment – expression and imaging (e.g., infrared meibography) evaluate oil layer function.
• Osmolarity Testing – increased tear osmolarity (>308 mOsm/L) is a hallmark of dry eye.

Additional Tests (if indicated)

• Blood work for autoimmune markers (ANA, rheumatoid factor, SS‑A/SS‑B antibodies) when Sjögren’s syndrome is suspected.
• Contact lens fitting assessment.
• Imaging of the lacrimal glands with ultrasound or MRI if structural disease is a concern.

Treatment Options

Treatment is personalized based on severity, underlying cause, and patient preference. Goals are to restore a stable tear film, reduce inflammation, and protect the ocular surface.

1. Home and Lifestyle Measures

• Environmental control – use humidifiers, avoid direct drafts, and wear wrap‑around sunglasses outdoors.
• Computer ergonomics – follow the 20‑20‑20 rule (every 20 min, look at something 20 ft away for 20 seconds) and keep screens at eye level to reduce blink suppression.
• Lid hygiene – warm compresses (5‑10 minutes) followed by gentle lid scrubs with diluted baby shampoo or commercial lid wipes.
• Hydration & diet – increase water intake; consider omega‑3 fatty acids (e.g., fish oil, flaxseed) which may improve meibomian gland function (supported by a meta‑analysis in *Ophthalmology* 2020).
• Medication review – discuss with your physician whether any current drugs might be contributing and whether alternatives exist.

2. Over‑the‑Counter (OTC) Lubricants

• Artificial tears – preservative‑free formulations are preferred for frequent use.
• Gel or ointment drops – provide longer‑lasting relief, especially at night.
• Lubricating eye masks or punctal plugs (temporary silicone plugs) – help retain existing tears.

3. Prescription Medications

• Cycloplegic anti‑inflammatories – cyclosporine ophthalmic (Restasis®) or lifitegrast (Xiidra®) improve tear production by modulating ocular surface inflammation.
• Tetracycline class antibiotics (doxycycline 40 mg daily) – reduce inflammation of the meibomian glands and decrease matrix metalloproteinase activity.
• Topical corticosteroids – short‑term use for acute flare‑ups under close supervision.
• Autologous serum eye drops – for severe, refractory cases; they contain growth factors and vitamin A.

4. Procedural Interventions

• Punctal occlusion – permanent silicone plugs or cauterization to block tear drainage.
• Meibomian gland expression – performed in‑office with heat and gentle pressure to clear obstructed glands.
• Intense pulsed light (IPL) therapy – emerging evidence shows IPL can improve meibomian gland function and reduce inflammation.
• Thermal pulsation devices (e.g., LipiFlow®) – apply controlled heat and pressure to melt and express meibum.

Prevention Tips

While not all cases are preventable, many lifestyle adjustments can lower the risk or lessen severity:

• Take regular breaks during screen time and practice conscious blinking.
• Avoid smoking and second‑hand smoke, which irritate the ocular surface.
• Wear protective eyewear in windy, dusty, or air‑conditioned environments.
• Maintain a balanced diet rich in omega‑3 fatty acids, vitamin A, and antioxidants.
• Stay hydrated—aim for at least 8 cups of water daily.
• Schedule routine eye exams, especially if you have risk factors such as autoimmune disease or are over 50.

Emergency Warning Signs

Key Take‑aways

Keratitis sicca (dry eye) is a common, often chronic condition that can significantly affect quality of life. Understanding the underlying causes, recognizing early symptoms, and seeking appropriate evaluation are essential to prevent complications such as corneal erosion or infection. With a combination of environmental modifications, proper eyelid care, lubricating drops, and targeted medical therapy, most people achieve satisfactory relief.

For further reading, consult reputable sources such as the CDC Vision Health Initiative, NIH NICHD, and the latest review articles in Ophthalmology and American Journal of Ophthalmology.

```